Lv1
10 积分 2026-01-07 加入
Regulation of p53 stability as a therapeutic strategy for cancer
4个月前
已完结
How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
4个月前
已完结
Pharmacological reactivation of p53 in the era of precision anticancer medicine
4个月前
已完结
Translating p53-based therapies for cancer into the clinic
4个月前
已完结
Targeting paraptosis in cancer: opportunities and challenges
5个月前
已完结
MIRA-1, a p53mut reactivator, is active on Temozolomide-resistant glioblastoma in vitro
7个月前
已完结
Acetylation promotes mutant (MUT) TP53-HSPA8 and HSPA8-BAG3 interactions, facilitating MUT TP53 lysosomal degradation preferentially via CASA
7个月前
已完结
皖公网安备34019202002308
